CNRS/UMR, 6061, IFR 140 Rennes University, Rennes, France.
Urol Oncol. 2012 Jul-Aug;30(4):469-75. doi: 10.1016/j.urolonc.2010.07.005. Epub 2010 Sep 21.
Literature controversies exist regarding the prognostic value of VHL mutations. The objective was to compare paraffin-embedded and frozen section specimens for VHL mutations detection and to evaluate the reliability of DNA analysis in formalin-fixed tissues.
Seventy-six patients with clear cell renal cell carcinoma (RCC) previously assessed for VHL status from frozen samples were included. Seventy-three tumor samples were known to be mutated for VHL. DNA was extracted and an electrophoresis was performed to determine DNA quality. The whole coding sequence was synthesized by double PCR amplification followed by sequencing. Sequencing results were compared with those previously determined from frozen samples.
DNA could be extracted from the 76 paraffin samples. DNA quality was highly degraded and significantly less amplified by PCR in 34.2%, resulting in no sequence available for analysis in 57.7% and discordance with frozen samples in 42.3% of the cases respectively. VHL mutations were found in 52.1% of the whole paraffin samples whereas 98% were mutated; 72% could be sequenced, resulting in 69.1% of VHL mutations in this subset. Only half of observed mutations were fully consistent with frozen analysis in the 3 exons. Neomutations were found in 10.5% and 28.9% of known mutations in frozen samples were not detected in paraffin blocks. Only DNA quality significantly influenced PCR amplification and sequencing.
Tumoral DNA extraction and VHL mutation analysis can be performed from formalin-fixed paraffin-embedded (FFPE) tissue in RCC. But mutations identified tissues are not strictly concordant with those from frozen analysis and therefore results obtained from FFPE samples should be interpreted with care.
关于 VHL 突变的预后价值,文献存在争议。目的是比较石蜡包埋和冰冻切片标本中 VHL 突变的检测,并评估福尔马林固定组织中 DNA 分析的可靠性。
纳入 76 例曾用冰冻样本检测 VHL 状态的透明细胞肾细胞癌(RCC)患者。73 例肿瘤样本已知 VHL 突变。提取 DNA 并进行电泳以确定 DNA 质量。通过双 PCR 扩增合成整个编码序列,然后进行测序。将测序结果与先前从冰冻样本中确定的结果进行比较。
76 例石蜡样本均可提取 DNA。34.2%的 DNA 质量高度降解,PCR 扩增显著减少,导致 57.7%的样本无法进行分析,42.3%的样本与冰冻样本不一致。52.1%的整个石蜡样本发现 VHL 突变,98%为突变;72%可测序,该亚组中有 69.1%的 VHL 突变。在 3 个外显子中,只有一半的观察到的突变与冰冻分析完全一致。在冰冻样本中发现新突变 10.5%,而在石蜡块中未检测到 28.9%的已知突变。只有 DNA 质量显著影响 PCR 扩增和测序。
可以从 RCC 的福尔马林固定石蜡包埋(FFPE)组织中提取肿瘤 DNA 并进行 VHL 突变分析。但鉴定的突变组织与冰冻分析不完全一致,因此应谨慎解释 FFPE 样本的结果。